Titan Pharmaceuticals Announces Agreement in Principle on Path Forward for … – MarketWatch

Titan Pharmaceuticals Announces Agreement in Principle on Path Forward for … – MarketWatch

Titan Pharmaceuticals Announces Agreement in Principle on Path Forward for
MarketWatch
The proposed clinical study will be a randomized, double blind and double dummy design that will provide information for a non-inferiority comparison of a six-month treatment with a dose of four Probuphine implants to treatment with 8mg or less of an

and more »

Methadone Maintenance – Google News

More Methadone Maintenance Information…